Sonoma Pharmaceuticals, Inc.
NASDAQSNOA cost to borrow surged 262% over the past week to 4.54%, coinciding with short interest spiking 3,758% to 26.5% of float.
Short interest % of float, cost to borrow, utilization, and put/call ratio for SNOA are part of the ORTEX premium tier. Sign up to read the live numbers alongside the analysis.
No long-form analysis yet for SNOA. Pulse alerts and the live data picture are available on ORTEX.
Open SNOA on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for SNOA — free to start on ORTEX.
Sign up for free →Open SNOA on ORTEXSnapshot as of 7 May 2026
Pulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live SNOA data →